BALLESTRI, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.779
AS - Asia 2.595
EU - Europa 2.406
SA - Sud America 351
Continente sconosciuto - Info sul continente non disponibili 86
AF - Africa 51
OC - Oceania 13
Totale 12.281
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.688
SG - Singapore 838
CN - Cina 648
GB - Regno Unito 604
IT - Italia 313
VN - Vietnam 308
FI - Finlandia 285
HK - Hong Kong 285
BR - Brasile 255
PL - Polonia 243
SE - Svezia 232
DE - Germania 215
BD - Bangladesh 131
RU - Federazione Russa 111
FR - Francia 104
UA - Ucraina 99
TR - Turchia 82
IN - India 59
BG - Bulgaria 48
CA - Canada 44
ID - Indonesia 39
JP - Giappone 39
AR - Argentina 35
KR - Corea 32
LT - Lituania 28
NL - Olanda 26
MX - Messico 21
MY - Malesia 16
PK - Pakistan 16
ZA - Sudafrica 16
IQ - Iraq 15
VE - Venezuela 15
EC - Ecuador 13
ES - Italia 13
PH - Filippine 12
IE - Irlanda 11
CZ - Repubblica Ceca 10
GR - Grecia 10
UZ - Uzbekistan 10
BE - Belgio 9
SA - Arabia Saudita 9
CO - Colombia 8
AU - Australia 7
BO - Bolivia 7
CL - Cile 7
AT - Austria 6
EG - Egitto 6
JM - Giamaica 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PE - Perù 6
RO - Romania 6
AE - Emirati Arabi Uniti 5
KE - Kenya 5
OM - Oman 5
SI - Slovenia 5
AL - Albania 4
DZ - Algeria 4
EU - Europa 4
GT - Guatemala 4
MA - Marocco 4
SV - El Salvador 4
TH - Thailandia 4
TW - Taiwan 4
CH - Svizzera 3
CR - Costa Rica 3
IL - Israele 3
JO - Giordania 3
LB - Libano 3
RS - Serbia 3
TN - Tunisia 3
UY - Uruguay 3
AZ - Azerbaigian 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GE - Georgia 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
NO - Norvegia 2
PT - Portogallo 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
TJ - Tagikistan 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
EE - Estonia 1
GH - Ghana 1
Totale 12.182
Salva come PNG Salva come JPEG
Città #
Fairfield 759
Ashburn 656
Singapore 551
Santa Clara 516
Woodbridge 462
Houston 364
Seattle 338
Southend 338
Chandler 312
Wilmington 301
Hong Kong 281
Helsinki 255
Cambridge 246
San Jose 241
Warsaw 241
Dearborn 192
Ann Arbor 182
Nyköping 165
Jacksonville 137
Beijing 132
Council Bluffs 125
New York 124
London 116
Chicago 113
Hefei 108
Los Angeles 105
Ho Chi Minh City 87
Modena 80
Hanoi 76
The Dalles 56
Sofia 46
Princeton 44
Eugene 43
Izmir 43
Salt Lake City 43
San Diego 43
Lauterbourg 36
Moscow 35
Milan 32
Shanghai 31
Dallas 30
Seoul 30
Buffalo 28
Frankfurt am Main 25
Tokyo 25
Jakarta 24
São Paulo 24
Munich 23
Boardman 21
Phoenix 21
Tampa 21
Manchester 19
Elk Grove Village 18
Columbus 17
Orem 17
Redwood City 17
Chennai 15
Denver 15
Des Moines 15
Da Nang 14
San Mateo 13
Amsterdam 12
Haiphong 12
Atlanta 11
Dublin 11
Guangzhou 11
Rome 11
Athens 10
Dong Ket 10
Kansas City 10
Naples 10
Bremen 9
Florence 9
Kunming 9
Lancaster 9
North Salt Lake 9
Paris 9
Redondo Beach 9
San Francisco 9
Tashkent 9
Biên Hòa 8
Bologna 8
Brno 8
Brussels 8
Jersey City 8
Johannesburg 8
Mexico City 8
Miano 8
Nanjing 8
Padova 8
Palisades Park 8
Schiffdorf 8
Baghdad 7
Brooklyn 7
Buenos Aires 7
Falls Church 7
Kuala Lumpur 7
Norwalk 7
Poplar 7
Rio de Janeiro 7
Totale 8.828
Salva come PNG Salva come JPEG
Nome #
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 498
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study 443
Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes 434
Human Immunodeficiency Virus Is the Major Determinant of Steatosis and Hepatitis C Virus of Insulin Resistance in Virus-associated Fatty Liver Disease. 397
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 392
Review article: the metabolic syndrome and non-alcoholic fatty liver disease 388
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 376
Sofosbuvir-based therapy cures hepatitis C virus infection after prior treatment failures in a patient with concurrent lymphoma 370
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 370
Genetic determinants of susceptibility and severity in nonalcoholic fatty liver disease. 370
Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels? 365
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 339
Hepatitis C virus-infected patients are 'spared' from the metabolic syndrome but not from insulin resistance. A comparative study of nonalcoholic fatty liver disease and hepatitis C virus-related steatosis 331
Nonalcoholic fatty liver disease and aging: epidemiology to management 325
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 323
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 315
A critical appraisal of the use of ultrasound in hepatic steatosis 307
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 302
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 295
Magnetic resonance for quantitative assessment of liver steatosis: a new potential tool to monitor antiretroviral-drug-related toxicities. 291
Is cholangiocarcinoma another complication of insulin resistance: A report of three cases 290
Treatment of atherogenic liver based on the pathogenesis of nonalcoholic Fatty liver disease: a novel approach to reduce cardiovascular risk? 285
Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. 277
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 277
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 276
Alcohol and Steatosis: The Japanese Paradox 275
Do diabetes and obesity promote hepatic fibrosis in familial heterozygous hypobetalipoproteinemia? 249
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 245
Non-alcoholic Fatty Liver Disease: a HR-MAS analysis 233
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 232
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 229
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 211
The neck-liver axis. Madelung disease as further evidence for an impact of body fat distribution on hepatic histology 203
Nanoparticles: potential toxins for the organism and the kidney ? 201
Gli enzimi epatobiliari nella diagnostica clinica delle Epatopatie. 201
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 199
Hypervascular Retroperitoneal Mass in a Patient with Fever and Leucocytosis - Contrast-Enhanced Ultrasonographic Findings in a Case of Inflammatory Malignant Fibrous Histiocytoma 195
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 195
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 193
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 179
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 168
Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease 132
Extra-hepatic manifestations and complications of nonalcoholic fatty liver disease 105
Totale 12.281
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.285
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.285
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022748 0 95 77 31 17 37 48 29 102 75 172 65
2022/2023827 82 126 62 76 87 116 16 79 96 8 34 45
2023/2024457 15 25 42 24 97 61 21 39 10 4 56 63
2024/20251.754 48 21 36 121 361 252 143 135 178 71 167 221
2025/20264.164 221 108 241 411 652 562 602 177 430 302 222 236
2026/2027205 109 96 0 0 0 0 0 0 0 0 0 0
Totale 12.281